Sunshine Biopharma (SBFM) Change in Inventory (2018 - 2026)

Sunshine Biopharma's Change in Inventory history runs 9 years deep, the most recent figure standing at -$78399.0 for Q1 2026.

• Quarterly Change in Inventory fell 113.78% year-over-year to -$78399.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $990044.0 (down 77.88% YoY) and the FY2025 annual result came in at $1.6 million, down 72.74% from the prior year.
• Change in Inventory was -$78399.0 for Q1 2026 at Sunshine Biopharma, up from -$772796.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $2.1 million in Q1 2024 and bottomed at -$772796.0 in Q4 2025.
• A 5-year average of $581665.2 and a median of $467925.0 in 2023 frame the typical range for Change in Inventory.
• Peak annual rise in Change in Inventory reached 2456.77% in 2022, while the deepest fall reached 702.72% in 2022.
• Sunshine Biopharma's Change in Inventory stood at -$206974.0 in 2022, then soared by 652.94% to $1.1 million in 2023, then surged by 57.71% to $1.8 million in 2024, then tumbled by 142.82% to -$772796.0 in 2025, then soared by 89.86% to -$78399.0 in 2026.
• Business Quant data shows SBFM's Change in Inventory at -$78399.0 in Q1 2026, -$772796.0 in Q4 2025, and $1.3 million in Q3 2025.